Schedule 13G ownership disclosure
SCPHARMACEUTICALS INC
Security class unavailable · CUSIP: 810648105
Event date: 2019-12-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,938,215
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-029716
- Form type
- SC 13G
- Filer
- SUNESIS PHARMACEUTICALS INC
- CIK
- CIK 1061027
- Filed
- Mar 05, 2020
- Reporting period
- Dec 05, 2019
- Description
- Schedule 13G beneficial ownership